Sairaj Satarker

Manipala, KA 576104, India

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 24 publications

Substance P mitigates lipopolysaccharide induced cognitive impairment in rats in a dose dependent manner.

Substance P mitigates lipopolysaccharide induced cognitive impairment in rats in a dose dependent manner.

Journal: Neuropeptides

Published: May 23, 2025

Histone Deacetylase 2 in Alzheimer's Disease: A Comprehensive Molecular Blueprint for Therapeutic Targeting.

Histone Deacetylase 2 in Alzheimer's Disease: A Comprehensive Molecular Blueprint for Therapeutic Targeting.

Journal: Molecular neurobiology

Published: April 15, 2025

Pharmacological inhibition of RE1 silencing transcription factor disrupts SOX2 expression and neurogenesis in human induced pluripotent stem cells derived neuronal models.

Pharmacological inhibition of RE1 silencing transcription factor disrupts SOX2 expression and neurogenesis in human induced pluripotent stem cells derived neuronal models.

Journal: Metabolic brain disease

Published: February 22, 2025

Recent advances in the molecular signaling pathways of Substance P in Alzheimer's disease: Link to neuroinflammation associated with toll-like receptors.

Recent advances in the molecular signaling pathways of Substance P in Alzheimer's disease: Link to neuroinflammation associated with toll-like receptors.

Journal: Biochemical and biophysical research communications

Published: June 20, 2024

Dopamine agonist Rotigotine mitigates lipopolysaccharide-induced neuroinflammation and memory impairment in mice.

Dopamine agonist Rotigotine mitigates lipopolysaccharide-induced neuroinflammation and memory impairment in mice.

Journal: Metabolic brain disease

Published: May 30, 2024

Epigenetic Alterations in Alzheimer's Disease: Impact on Insulin Signaling and Advanced Drug Delivery Systems.

Epigenetic Alterations in Alzheimer's Disease: Impact on Insulin Signaling and Advanced Drug Delivery Systems.

Journal: Biology

Published: January 20, 2024

Spermidine as an epigenetic regulator of autophagy in neurodegenerative disorders.

Spermidine as an epigenetic regulator of autophagy in neurodegenerative disorders.

Journal: European journal of pharmacology

Published: October 03, 2023

Evaluating the Role of N-Acetyl-L-Tryptophan in the Aβ 1-42-Induced Neuroinflammation and Cognitive Decline in Alzheimer's Disease.

Evaluating the Role of N-Acetyl-L-Tryptophan in the Aβ 1-42-Induced Neuroinflammation and Cognitive Decline in Alzheimer's Disease.

Journal: Molecular neurobiology

Published: September 27, 2023

In-silico lead identification of the pan-mutant IDH1 and IDH2 inhibitors to target glioblastoma.

In-silico lead identification of the pan-mutant IDH1 and IDH2 inhibitors to target glioblastoma.

Journal: Journal of biomolecular structure & dynamics

Published: May 25, 2023

Repressor Element-1 Binding Transcription Factor (REST) as a Possible Epigenetic Regulator of Neurodegeneration and MicroRNA-Based Therapeutic Strategies.

Repressor Element-1 Binding Transcription Factor (REST) as a Possible Epigenetic Regulator of Neurodegeneration and MicroRNA-Based Therapeutic Strategies.

Journal: Molecular neurobiology

Published: March 14, 2023

Astrocytic transcription factors REST, YY1, and putative microRNAs in Parkinson's disease and advanced therapeutic strategies.

Astrocytic transcription factors REST, YY1, and putative microRNAs in Parkinson's disease and advanced therapeutic strategies.

Journal: Gene

Published: March 13, 2023

Avanafil mediated dual inhibition of IKKβ and TNFR1 in an experimental paradigm of Alzheimer's disease: in silico and in vivo approach.

Avanafil mediated dual inhibition of IKKβ and TNFR1 in an experimental paradigm of Alzheimer's disease: in silico and in vivo approach.

Journal: Journal of biomolecular structure & dynamics

Published: December 19, 2022

Showing 1-12 of 24

Last Updated: 09/26/2026